References in bold have been published by MATHEC members
References in italics are to mesenchymal stromal cells.
2024
Prérequis et organisation du parcours de soins en vue de l’utilisation d’une thérapie cellulaire ou génique par cellules stromales mésenchymateuses (CSM) ou par cellules T porteuses d’un récepteur antigénique chimérique (CAR-T cells) chez les patients avec maladies auto-immunes systémiques
Castilla-Llorente C, Bonnin A, Lansiaux P, Tudesq J-J, Beuvon C, Fabreguettes J-R, Pers Y-M, Pugnet G, Maria A T J, Puyade M, Urbain F, Terriou L, Poindron V, Jachiet M, Cacciatore C, Lescoat A, Prata P H, Munia I, Madelaine I, Thieblemont C, Marjanovic Z
The Lancet Infectious Diseases Volume 24, Issue 5, May 2024, Pages e291-e306 doi.org/10.1016/j.bulcan.2024.06.008
Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022
Aerts R, Mehra V, Groll A H, Martino R, Lagrou K, Robin C, Perruccio K, Blijlevens N, Nucci M, Slavin M, Bretagne S, Cordonnier, on behalf of the European Conference on Infections in Leukaemia group
The Lancet Infectious Diseases Volume 24, Issue 5, May 2024, Pages e291-e306 doi.org/10.1016/S1473-3099(23)00495-4
International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges
Alsultan A, Farge D, Kili Sven, Forte M, Weiss D J, Grignon F, Boelens J J
Cytotherapy 000(2024)1-9, Available online 9 May 2024. doi.org/10.1016/j.jcyt.2024.05.007
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
Greco R , Alexander T, Del Papa N, Müller F, Saccardi R, Sanchez-Guijo F, Schett G, Sharrack B, Snowden J A, Tarte K, Onida F, Sánchez-Ortega I, Burman J, Castilla Llorente C, Cervera R, Ciceri F, Doria A, Henes J, Lindsay J, Mackensen A, Muraro P A, Ricart E, Rovira M, Zuckerman T, Yakoub-Agha I and Farge D
EClinicalMedicine. 2024 Feb 10:69:102476. doi: 10.1016/j.eclinm.2024.102476. eCollection 2024 Mar.
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)
Sanchez-Guijo F, Vives J, Ruggeri A, Chabannon C, Corbacioglu S, Dolstra H, Farge D, Gagelmann N, Horgan C, Kuball J, Neven B, Rintala T, Rocha V, Sanchez-Ortega I, Snowden J A, Zwaginga JJ, Gnecchi M, Sureda A
Cytotherapy 00 (2024) https://doi.org/10.1016/j.jcyt.2024.02.007
Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC
Bonnin A, Terriou L, Beuvon C, Tudesq JJ, Puyade M, Pugnet G, Maria A, Castilla Llorente C, Lansiaux P, Cacciatore C, Badoglio M, Yakoub-Agha I, Farge-Bancel D, Marjanovic Z
Bull Cancer 2024; 111: S84–S95. 2024 Feb 22. doi.org/10.1016/j.bulcan.2023.09.002
National diagnostic and care protocols (NDCP) for hematopoietic stem cell transplantation in autoimmune diseases
Farge D , Pugnet G, Allez M, Castilla-Llorente C, Chatelus E, Cintas P, Faucher-Barbey C, Labauge P, Labeyrie C, Lioure B, Maria A, Michonneau D, Puyade M, Talouarn M, Terriou L, Treton X, Wojtasik G, Zephir H, Marjanovic Z; MATHEC collaborators
Rev Med Interne. 2024 Jan 13:S0248-8663(24)00001-8. doi: 10.1016/j.revmed.2023.12.008.
2023
Actualisation des protocoles de mobilisation et conditionnement pour la pratique des autogreffes de cellules souches hématopoïétiques chez les patients atteints de maladies auto-immunes : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (MATHEC-SFGM-TC)
Bonnin A, Terriou L, Beuvon C, Tudesq JJ, Puyade M, Pugnet G, Maria A, Castilla Llorente C, Lansiaux P, Cacciatore C, Badoglio M, Yakoub-Agha I, Farge-Bancel D, Marjanovic Z
Bull Cancer. 2023 Oct 14:S0007-4551(23)00373-9. doi: 10.1016/j.bulcan.2023.09.002.
Mesenchymal Stromal Cells: Heterogeneity and Therapeutical Applications
Ouzin M and Kogler G
Cells 2023, 12(16), 2039; https://doi.org/10.3390/cells12162039
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
Saccardi R, Putter H, Eikema D-J, Busto M P, McGrath E, Middelkoop B, Adams G, Atlija M, Ayuk F A, Baldomero H, Beguin Y, de la Cámara R, Cedillo Á, Sureda Balari A M, Chabannon C, Corbacioglu S, Dolstra H, Duarte R F, Dulery R, Greco R, Gusi A, Hamad N, Kenyon M, Kröger N, Labopin M, Lee J, Ljungman P, Manson L, Mensil F, Milpied N, Mohty M, Oldani E, Orchard K, Passweg J, Pearce R, Peffault de Latour R, Poirel H A, Rintala T, Rizzo J D, Ruggeri A, Sanchez-Martinez C, Sanchez-Guijo F, Sánchez-Ortega I, Trnková M, Valcárcel Ferreiras D, Wilcox L, C. de Wreede L, and Snowden J A.
Bone Marrow Transplant. 2023; 58(6): 659–666.Published online 2023 Mar 9. doi: 10.1038/s41409-023-01924-6
Vaccinations avant et après greffe de cellules hématopoïétiques autologues chez les patients atteints de maladies auto-immunes : propositions du groupe Maladies Auto-immunes et Thérapie Cellulaire de la SFGM-TC
Maria A, Campidelli A, Castilla-Llorente C, Lansiaux P, Marjanovic Z, Pugnet G, Torregrosa-Diaz JM, Terriou L, Algayres JP, Urbain F, Yakoub-Agha I, Farge D.
Bull Cancer. 2023 Feb;110(2S):S97-S107. doi: 10.1016/j.bulcan.2022.11.005. Epub 2023 Jan 17.
2022
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: Where do we stand? Volume II
Malmegrim.K.C.R, Toubert.A, Farge.D, Oliveira.M.C
Front. Immunol., 14 October 2022 Sec. Alloimmunity and Transplantation.
Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products
Cuende N, Ciccocioppo R, Forte M, Galipeau J, Ikonomou L, Levine BL, Srivastava A, Zettler PJ
Cytotherapy. 2022 Jul;24(7):686-690.doi: 10.1016/j.jcyt.2022.03.007. Epub 2022 May 8.
Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation
Achini-Gutzwiller F R, Snowden J A, Corbacioglu S, Greco R, The EBMT Autoimmune Diseases (ADWP) and Paediatric Diseases (PDWP) Working Parties
Br J Haematol. 2022 Jul;198(1):24-45. doi: 10.1111/bjh.18176. Epub 2022 Apr 27
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome
Fernández-Santos ME, Garcia-Arranz M, Andreu EJ, García-Hernández AM, López-Parra M, Villarón E, Sepúlveda P, Fernández-Avilés F, García-Olmo D, Prosper F, Sánchez-Guijo F, Moraleda JM, Zapata AG
Front Immunol. 2022 Jun 9;13:918565.doi: 10.3389/fimmu.2022.918565. eCollection 2022.
Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion
Srinivasan A, Sathiyanathan P, Yin L, Liu T M, Lam A, Ravikumar M, Smith R A A, Loh H P, Zhang Y, Ling L, Ng S K, Yang Y S, Lezhava A, Hui J, Oh S, Cool S M
Cytotherapy.2022 May;24(5):456-472.doi:10.101/j.jcyt.2021.11.009. Epub 2022 Feb 25.
Single-cell RNA sequencing analysis of human bone-marrow-derived mesenchymal stem cells and functional subpopulation identification
Xie Z, Yu W, Ye G, Li J, Zheng G, Liu W, Lin J, Su Z, Che Y, Ye F, Zhang Z, Wang P, Wu Y, Shen H
Exp Mol Med. 2022 Apr 1.doi: 10.1038/s12276-022-00749-5. Online ahead of print.
Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy
Abdel-Azim H, Dave H, Jordan K, Rawlings-Rhea S, Luong A , Wilson AL
Cytotherapy. 2022 Feb;24(2):193-204.doi: 10.1016/j.jcyt.2021.08.007. Epub 2021 Oct 26.
2021
The Survey on Cellular and Tissue-Engineered Therapies in Europe in 2016 and 2017
Gay MHP, Baldomero H, Farge-Bancel D, Robey PG, Rodeo S, Passweg J, Müller-Gerbl M, Martin I
Tissue Eng Part A. 2021Mar;27(5-6):336-350.doi:10.1089/ten.TEA.2020.0092. Epub 2020 Sep 18.
Consensus International Council for Commonality in Blood Banking Automation-International Society for Cell & Gene Therapy statement on standard nomenclature abbreviations for the tissue of origin of mesenchymal stromal cells
Viswanathan S, Ciccocioppo R, Galipeau J, Krampera M, Le Blanc K, Martin I, Moniz K, Nolta J, Phinney DG, Shi Y, Szczepiorkowski ZM, Tarte K, Weiss DJ, Ashford P
Cytotherapy.2021Jun8;S1465-3249(21)00644-7.doi:10.1016/j.jcyt.2021.04.009
Suivi immunologique et collection biologique en vue de l’analyse de la réponse clinique après autogreffe de moelle pour maladies auto-immunes : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
Lansiaux P, Loisel S, Castilla-Llorente C, Fontenille C, Kabdani S, Marjanovic Z, Pugnet G, Puyade M, Robert E, Terriou L, Ait Abdallah N, Maria A, Michel L, Tréton X, Yakoub-Agha I, Farge D
Bull Cancer. 2021 Dec;108(12S):S72-S81. doi: 10.1016/j.bulcan.2021.03.020. Epub 2021 Jul 14.
Medication non-adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
Belaiche S, Décaudin B, Caron A, Depas N, Vignaux C, Vigouroux S, Coiteux V, Magro L, Sirvent A, Huynh A, Turlure P , Farge D, Lioure B , Bruno B, De Berranger E , Maillard N, Bourhis JH, Bay JO, Bulabois CE, Ceballos P , Fegueux N, Hicheri Y, Vincent L, Rialland F, Gandemer V, Taque S, Cornillon J, Contentin N, Galambrun C, Plantaz D, Odou P, Yakoub-Agha I
Fundam Clin Pharmacol. 2021 Apr;35(2):435-445. doi: 10.1111/fcp.12593. Epub 2021 Jan 7.
2020
An assessment of the hospital exemption landscape across European Member States: regulatory frameworks, use and impact
Hills A, Awigena-Cook J, Genenz K, Ostertag M, Butler S, Eggimann A-V, Hubert A
Cytotherapy. 2020 Dec;22(12):772-779.e1.doi: 10.1016/j.jcyt.2020.08.011. Epub 2020 Oct 10.
A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn’s disease. Position paper of the Brazilian Society of Bone Marrow Transplantation
Oliveira MC, Elias JB, Moraes DA, Simões BP, Rodrigues M, Ribeiro AAF, Piron-Ruiz L, Ruiz MA, Hamerschlak N.
Hematol Transfus Cell Ther. 2020 Apr 29:S2531-1379(20)30032-8. doi: 10.1016/j.htct.2020.03.002.
Mesenchymal Stromal Cell Therapeutic Potency Is Dependent Upon Viability, Route of Delivery, and Immune Match
Giri J, Galipeau J.
Blood Adv. 2020May12;4(9):1987-1997.doi:10.1182/bloodadvances.2020001711.
Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis.
Thompson M, Mei SHJ, Wolfe D, Champagne J, Fergusson D, Stewart DJ, Sullivan KJ, Doxtator E, Lalu M, English SW, Granton J, Hutton B, Marshall J, Maybee A, Walley KR, Santos CD, Winston B, McIntyre L.
EClinicalMedicine. 2020 Jan 17;19:100249
Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells.
Ménard C, Dulong J, Roulois D, Hébraud B, Verdière L, Pangault C, Sibut V, Bezier I, Bescher N, Monvoisin C, Gadelorge M, Bertheuil N, Flécher E, Casteilla L, Collas P, Sensebé L, Bourin P, Espagnolle N, Tarte K.
Stem Cells. 2020 Jan;38(1):146-159. doi: 10.1002/stem.3077. Epub 2019 Sep 10.
2019
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, Corbacioglu S, Dreger P, Dufour C, Gennery AR, Jürgen J, Lankester AC, Lanza F, Montoto S, Nagler A, Peffault de Latour R, Snowden JA, Styczynski J, Yakoub-Agha I, Kröger N, Mohty M, European Society for Blood and Marrow Transplantation (EBMT)
BoneMarrowTransplant.2019Oct;54(10):1525-1552.doi:10.1038/s41409-019-0516-2.
Autoimmune Disease
Alexander T, Sharrack B, Rovira M, Farge D, Snowden JA.
In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 91.
Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Miller PDE, Snowden JA, De Latour RP, Iacobelli S, Eikema DJ, Knol C, Marsh JCW, Rice C, Koh M, Fagioli F, Chaganti S, Finke J, Duarte RF, Bader P, Farge D, Passweg JR, Madrigal JA, Dufour C.
Bone Marrow Transplant. 2019 Sep 25. doi: 10.1038/s41409-019-0680-4.
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties
Greco R, Labopin M, Badoglio M, Veys P, Furtado Silva JM, Abinun M, Gualandi F, Bornhauser M, Ciceri F, Saccardi R, Lankester A, Alexander T, Gennery AR, Bader P, Farge D, Snowden JA.
Front Immunol. 2019 Jul 4;10:1570. doi: 10.3389/fimmu.2019.01570. eCollection 2019.
Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cells activity.
Cheung TS, Galleu A, von Bonin M, Bornhäuser M, Dazzi F.
Haematologica.2019Mar7.pii:haematol.2018.214767.doi:10.3324/haematol.2018.214767.
First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue
Couto PS, Shatirishvili G, Bersenev A, Verter F.
Regen Med. 2019 May 9. doi: 10.2217/rme-2018-0171. [Epub ahead of print]
Haematopoietic stem cell transplants: principles and indications.
Balassa K, Danby R, Rocha V.
Br J Hosp Med (Lond). 2019 Jan 2;80(1):33-39. doi: 10.12968/hmed.2019.80.1.33.
General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Jessop H, Farge D, Saccardi R, Alexander T, Rovira M, Sharrack B, Greco R, Wulffraat N, Moore J, Kazmi M, Badoglio M, Adams G, Verhoeven B, Murray J, Snowden JA.
Bone Marrow Transplant. 2019 Jan 31. doi: 10.1038/s41409-019-0430-7
Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Guillaume-Jugnot P, Badoglio M, Labopin M, Terriou L, Yakoub-Agha I, Martin T, Lioure B, Marjanovic Z, Blaise D, Nguyen S, Pugnet G, Huynh A, Deligny C, Seinturier C, Garban F, Swiader L, Bay JO, Braun T, de Latour RP, Rubio MT, Farge D.
Clin Rheumatol. 2019 Jan 21. doi: 10.1007/s10067-019-04435-2
2018
Mesenchymal-myeloid interaction in the regulation of immunity.
Cheung TS, Dazzi F.
Semin Immunol. 2018 Feb;35:59-68. doi: 10.1016/j.smim.2018.01.002.
Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers.
Malmegrim KCR, Lima-Júnior JR, Arruda LCM, de Azevedo JTC, de Oliveira GLV, Oliveira MC.
Front Immunol. 2018 Nov 16;9:2602. doi: 10.3389/fimmu.2018.02602.
Clear up this stem-cell mess.
Sipp D, Robey PG, Turner L.
Nature. 2018 Sep;561(7724):455-457
Hematopoietic stem cell therapy for autoimmune diseases – Clinical experience and mechanisms.
Alexander T, Farge D, Badoglio M, Lindsay JO, Muraro PA, Snowden JA; Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).
J Autoimmun. 2018 Jun 19.
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.
Galipeau J, Sensébé L.
Cell Stem Cell. 2018 Jun 1;22(6):824-833
Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape.
Dessels C, Alessandrini M, Pepper MS.
Stem Cells Transl Med. 2018 May 18.
Applied Bayesian Methods in the Rheumatic Diseases.
Johnson SR, Tomlinson GA, Granton JT, Hawker GA, Feldman BM.
Rheum Dis Clin North Am. 2018 May;44(2):361-370
2017
How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)
Brissot E, Alsuliman T, Gruson B, Hermet E, Tirefort Y, Yakoub-Agha I, Alain S
Bull Cancer déc 2017; 104S: S181–S187. doi.org/10.1016/j.bulcan.2017.10.022
Le passage à l’échelle industrielle de la production de cellules souches à usage thérapeutique.
Raymond ARDAILLOU, Bruno JARRY et Jean-François STOLTZ
Académie Nationale de Médecine- Rapport de la séance du 05/12/2017
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases
John A. Snowden, Manuela Badoglio, Myriam Labopin, Sebastian Giebel, Eoin McGrath, Zora Marjanovic, Joachim Burman, John Moore, Montserrat Rovira, Nico M. Wulffraat, Majid Kazmi, Raffaella Greco, Emilian Snarski, Tomas Kozak, Kirill Kirgizov, Tobias Alexander, Peter Bader, Riccardo Saccardi and Dominique Farge for the European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), EBMT Paediatric Working Party (PWP), and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE)
Blood Advances 2017 1:2742-2755
Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Pugnet G, Castilla-Llorente C, Puyade M, Terriou L, Badoglio M, Deligny C, Guillaume-Jugnot P, Labeyrie C, Benzidia I, Faivre H, Lansiaux P, Marjanovic Z, Bourhis JH, Faucher C, Furst S, Huynh A, Martin T, Vermersch P, Yakoub-Agha I, Farge D.
Bull Cancer. 2017 Nov 21. pii: S0007-4551(17)30271-0
Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.
Keever-Taylor CA, Heimfeld S, Steinmiller KC, Nash RA, Sullivan KM, Czarniecki CW, Granderson TC, Goldstein JS, Griffith LM.
Biol Blood Marrow Transplant. 2017 Sep;23(9):1463-1472
Oral health of adult patients undergoing hematopoietic cell transplantation. Pre-transplant assessment and care.
Boguslawska-Kapala A, Halaburda K, Rusyan E, Golabek H, Struzycka I
Ann Hematol. 2017 Jul;96(7):1135-1145.
Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications.
Cagliani J, Grande D, Molmenti EP, Miller EJ, Rilo HLR.
Ann Hematol. 2017 Jul;96(7):1135-1145.
Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT).
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M.
Bone Marrow Transplant. 2017 Feb;52(2):191-196.
2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M.
Bone Marrow Transplant. 2016 Jun;51(6):786-92. doi: 10.1038/bmt.2016.20.
Mesenchymal stem cells for treating autoimmune diseases: The Chinese experience from lab to clinics.
Liang J, Wang D, Farge D, Sun L.
Curr Res Transl Med. 2016 Apr-Jun;64(2):115-20
Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.
Arruda LC, Clave E, Moins-Teisserenc H, Douay C, Farge D, Toubert A.
Curr Res Transl Med. 2016 Apr-Jun;64(2):107-13. doi: 10.1016/j.retram.2016.03.004.
Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice.
Kelsey PJ, Oliveira MC, Badoglio M, Sharrack B, Farge D, Snowden JA.
Curr Res Transl Med. 2016 Apr-Jun;64(2):71-82. doi: 10.1016/j.retram.2016.03.003.
Tumor necrosis factor inhibitors added to nonbiological immunosuppressants vs. nonbiological immunosuppressants alone: a different signal of cancer risk according to the condition. A disproportionality analysis in a nationwide pharmacovigilance database.
Saliba L, Moulis G, Abou Taam M, Rousseau V, Chebane L, Petitpain N, Baldin B, Pugnet G, Montastruc JL, Bagheri H.
Fundam Clin Pharmacol. 2016 Apr;30(2):162-71. doi: 10.1111/fcp.12171.
The use of hematopoietic stem cells in autoimmune diseases.
Ben Nasr M, Bassi R, Usuelli V, Valderrama-Vasquez A, Tezza S, D’Addio F, Fiorina P.
Regen Med. 2016 Jun;11(4):395-405
2015
Autologous hematopoietic stem cell transplantation reverses skin fibrosis but does not change skin vessel density in patients with systemic sclerosis.
Daikeler T, Kump E, Stern M, Hügle T, Hij A, Haeuserman P, Farge D.
Pathol Biol (Paris). 2015 Sep;63(4-5):164-8
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.
Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Marsh JC, Nagler A, Peters C, Velardi A, Mohty M, Madrigal A.
Bone Marrow Transplant. 2015 Aug;50(8):1037-56. doi: 10.1038/bmt.2015.6.
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M; European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2015 Apr;50(4):476-82. doi: 10.1038/bmt.2014.312.
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).
Snarski E, Snowden JA, Oliveira MC, Simoes B, Badoglio M, Carlson K, Burman J, Moore J, Rovira M, Clark RE, Saiz A, Hadj-Khelifa S, Tan J, Crescimanno A, Musso M, Martin T, Farge D.
Bone Marrow Transplant. 2015 Feb;50(2):216-20. doi: 10.1038/bmt.2014.248.
SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking.
Alexander T, Bondanza A, Muraro PA, Greco R, Saccardi R, Daikeler T, Kazmi M, Hawkey C, Simoes BP, Leblanc K, Fibbe WE, Moore J, Snarski E, Martin T, Hiepe F, Velardi A, Toubert A, Snowden JA, Farge D
Bone Marrow Transplant. 2015 Feb;50(2):173-80. doi: 10.1038/bmt.2014.251.
2014
Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC.
Farge D, Terriou L, Badoglio M, Cras A, Desreumaux P, Hadj-Khelifa S, Marjanovic Z, Moisan A, Dulery R, Faucher C, Hij A, Martin T, Vermersch P, Yakoub-Agha I; SFGM-TC.
Pathol Biol (Paris). 2014 Aug;62(4):204-8. doi: 10.1016/j.patbio.2014.05.012.
Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation.
Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Farge-Bancel D, Gennery A, Halter J, Kröger N, Lanza F, Marsh J, Mohty M, Sureda A, Velardi A, Madrigal A; European Society for Blood and Marrow Transplantation EBMT.
Bone Marrow Transplant. 2014 Jun;49(6):744-50. doi: 10.1038/bmt.2014.55.
2013
Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis.
Rodrigues MC1, Hamerschlak N, de Moraes DA, Simões BP, Rodrigues M, Ribeiro AA, Voltarelli JC.
Rev Bras Hematol Hemoter. 2013;35(2):134-43. doi: 10.5581/1516-8484.20130035.
Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application.
Ménard C, Tarte K.
Stem Cell Res Ther. 2013 Jun 6;4(3):64
Progranulin antibodies in autoimmune diseases.
Thurner L, Preuss KD, Fadle N, Regitz E, Klemm P, Zaks M, Kemele M, Hasenfus A, Csernok E, Gross WL, Pasquali JL, Martin T, Bohle RM, Pfreundschuh M.
J Autoimmun. 2013 May;42:29-38. doi: 10.1016/j.jaut.2012.10.003.
New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation.
Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA, Carlson K, Cornillon J, Diez-Martin JL, Gandemer V, Faraci M, Lindemans C, O’Meara A, Mialou V, Renard M, Sedlacek P, Sirvent A, Socié G, Sora F, Varotto S, Sanz J, Voswinkel J, Vora A, Yesilipek MA, Herr AL, Gluckman E, Farge D, Rocha V.
Blood. 2013 Feb 7;121(6):1059-64. doi: 10.1182/blood-2012-07-445965.
2012
The EBMT activity survey: 1990-2010.
Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A; European Group for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2012 Jul;47(7):906-23. doi: 10.1038/bmt.2012.66.
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.
Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G, Martin R, Moore JJ, Passweg J, Peters C, Rabusin M, Rovira M, van Laar JM, Farge D; EBMT Autoimmune Disease Working Party (ADWP); Paediatric Diseases Working Party (PDWP).
Bone Marrow Transplant. 2012 Jun;47(6):770-90. doi: 10.1038/bmt.2011.185.
Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009.
Snowden JA, Pearce RM, Lee J, Kirkland K, Gilleece M, Veys P, Clark RE, Kazmi M, Abinun M, Jackson GH, Mackinnon S, Russell NH, Cook G; BSBMT Clinical Trials Committee.
Br J Haematol. 2012 Jun;157(6):742-6. doi: 10.1111/j.1365-2141.2012.09122.x.
Control of B cells expressing naturally occurring autoantibodies.
Pasquali JL, Martin T.
Adv Exp Med Biol. 2012;750:145-56. doi: 10.1007/978-1-4614-3461-0_11.
2011
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party.
Daikeler T, Labopin M, Di Gioia M, Abinun M, Alexander T, Miniati I, Gualandi F, Fassas A, Martin T, Schwarze CP, Wulffraat N, Buch M, Sampol A, Carreras E, Dubois B, Gruhn B, Güngör T, Pohlreich D, Schuerwegh A, Snarski E, Snowden J, Veys P, Fasth A, Lenhoff S, Messina C, Voswinkel J, Badoglio M, Henes J, Launay D, Tyndall A, Gluckman E, Farge D; EBMT Autoimmune Disease Working Party.
Blood. 2011 Aug 11;118(6):1693-8. doi: 10.1182/blood-2011-02-336156.
2010
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.
Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, Ouyang J, Kozak T, Moore J, Kötter I, Chesnel V, Marmont A, Gratwohl A, Saccardi R.
Haematologica. 2010 Feb;95(2):284-92.
2009
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.
Avanzini MA, Bernardo ME, Cometa AM, Perotti C, Zaffaroni N, Novara F, Visai L, Moretta A, Del Fante C, Villa R, Ball LM, Fibbe WE, Maccario R, Locatelli F.
Haematologica. 2009 Dec;94(12):1649-60. doi: 10.3324/haematol.2009.006171.
Allogeneic hematopoietic SCT for patients with autoimmune diseases.
Daikeler T, Hügle T, Farge D, Andolina M, Gualandi F, Baldomero H, Bocelli-Tyndall C, Brune M, Dalle JH, Urban C, Ehninger G, Gibson B, Linder B, Lioure B, Marmont A, Matthes-Martin S, Nachbaur D, Schuetz P, Tyndall A, van Laar JM, Veys P, Saccardi R, Gratwohl A; Working Party Autoimmune Diseases of the EBMT.
Bone Marrow Transplant. 2009 Jul;44(1):27-33. doi: 10.1038/bmt.2008.424.
Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?
Larghero J, Vija L, Lecourt S, Michel L, Verrecchia F, Farge D.
Rev Med Interne. 2009 Mar;30(3):287-99. doi: 10.1016/j.revmed.2008.08.019
2005
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X; Club Rheumatismes et Inflammation (CRI).
Ann Rheum Dis. 2005 Jun;64(6):913-20.
Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kötter I, Kozak T, Lisukov I, Löwenberg B, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW, Tyndall A; Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2005 May;35(9):869-79.
Progress in hematopoietic stem cell transplantation for autoimmune diseases
Tyndall A, Farge D.
Expert Rev Clin Immunol. 2005 May; 1(1):159-67. doi: 10.1586/1744666X.1.1.159.
2004
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis.
Saccardi R, Tyndall A, Coghlan P, Denton C, Edan G, Emdin M, Farge D et al.
Bone Marrow Transplant. 2004 Nov;34(10):877-81.
Antiphospholipid antibodies: recent progresses on their origin and pathogenicity.
Pasquali JL, Nehme H, Korganow AS, Martin T.
Joint Bone Spine. 2004 May;71(3):172-4.
2003
Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals.
Lieby P, Soley A, Knapp AM, Cerutti M, Freyssinet JM, Pasquali JL, Martin T.
Blood. 2003 Oct 1;102(7):2459-65. Epub 2003 Jun 5.
1999
Treatment of severe autoimmune diseases by immunoablative chemotherapy and autologous bone marrow transplantation
Farge D, Gluckman E, Tyndallc A.
European Journal of Internal medicine 1999 ; 10 :88-96
From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins.
Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali JL, Benoist C, Mathis D.
Immunity. 1999 Apr;10(4):451-61.
1994
Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain.
Martin T, Crouzier R, Weber JC, Kipps TJ, Pasquali JL.
J Immunol. 1994 Jun 15;152(12):5988-96.
1992
Evidence for somatic selection of natural autoantibodies.
Martin T, Duffy SF, Carson DA, Kipps TJ.
J Exp Med. 1992 Apr 1;175(4):983-91.